Home
Explore services
Integrated solutions
Data & analytics
Tailored Reporting
Strategy & consulting
AI
Industry focus
Enterprise, mid-market & emerging pharmaceutical
Biotechnology
Financial Institutions
Education
Professional services
How we help
Pricing strategy & market access
Health technology assessment
Regulatory compliance
Commercial strategy & launch planning
Contact us
Responsive Menu
Home
Explore services
▼
Integrated solutions
Data & analytics
Tailored Reporting
Strategy & consulting
AI
Industry focus
▼
Enterprise, mid-market & emerging pharmaceutical
Biotechnology
Financial Institutions
Education
Professional services
How we help
▼
Pricing strategy & market access
Health technology assessment
Regulatory compliance
Commercial strategy & launch planning
Contact us
LOGIN
Research Insights
Impact of first-to-market product on orphan designation status for subsequent products in the EU4
22 January 2025
Read More
Named Patient Programs as an access pathway in Germany, France, and the UK
15 January 2025
Read More
South Korea Unveils Five-Year Roadmap to Advance AI in Healthcare
13 January 2025
Read More
Preparing for Joint Clinical Assessments: To PICO or Not to PICO?
9 January 2025
Read More
Pricing and Reimbursement Trends in Europe: Current Landscape and Implications
7 January 2025
Read More
Insights into value-based pricing approaches for oncology products in Germany
29 November 2024
Read More
Artificial intelligence in pharma access and pricing – will it take over from humans or enhance our understanding?
3 April 2024
Read More
Machine Learning for Value-Based Pricing
21 March 2024
Read More
Evolving Pharmaceutical Pricing: Dynamic Value-Based Models for Market Success
15 February 2024
Read More
The challenge of Healthcare Resource Use (HRU) Data in Low and Middle-Income Countries (LMICs)
6 February 2024
Read More
1
2
3
Next »
Yearly Archives
2025
2024
2023
2022
2021
Stay Informed
Sign up to receive the latest news and trends
straight into your inbox from GPI